pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,082 catalysts · 5,159 phase readout · 2,355 8k filing · 316 pdufa · 275 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 60 catalysts2026-07-30: 13 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,159
  • 8k filing2,355
  • pdufa316
  • earnings275
  • phase 2 completion108
  • phase 1 completion50
  • phase 1 2 completion28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area
    • Oncology87
    • Cardiology23
    • Immunology15
    • Infectious Disease12
    • Dermatology12
    • Ophthalmology8
    • Women's Health8
    • Pulmonology8
    • Pain6

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT07553221: Talar Osteochondral Lesions With Pilon Fractures

    Sponsor: University of Missouri-Columbia. Phase: NA. Conditions: Pilon Fractures

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07506421: Hope Groups: Parenting and Mental Health Among Refugees in the Middle East

    Sponsor: University of Oxford. Phase: NA. Conditions: Mental Health, Violence Against Children

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07473414: Synovial Tissue as a Biomarker in the Early Management of Osteoarthritis

    Sponsor: Nantes University Hospital. Phase: NA. Conditions: Osteoarthritis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07371416: Regenerative Root Canal Treatment of Immature Teeth Using Omega-3 Fatty Acids

    Sponsor: Mansoura University. Phase: NA. Conditions: Immature Permanent Teeth With Open Apex, Pulp Necrosis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07469306: Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

    Sponsor: Fujian Cancer Hospital. Phase: PHASE2. Conditions: Locally Advanced Rectal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07100106: A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

    Sponsor: Genentech, Inc.. Phase: PHASE1. Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06736704: SNV4818 in Participants With Advanced Solid Tumors

    Sponsor: Pikavation Therapeutics, Inc.. Phase: PHASE1. Conditions: Advanced Solid Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07384806: Functional Training in Adolescent Table Tennis

    Sponsor: Alirıza Han Civan. Phase: NA. Conditions: Functional Training in Adolescent Table Tennis Players

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07536204: Characterization of JAK1 and JAK2 Activation in Gingival Tissues During Homeostasis and Periodontitis

    Sponsor: University of Chile. Phase: . Conditions: Periodontitis, Periodontal Diseases, Periodontal Inflammation, Gingival Diseases, Periodontal Attachment Loss

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00373347: Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma

    Sponsor: Stanford University. Phase: . Conditions: Liver Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07331649: Comparative Effects of Modified Tabata Training and Fartlek Training in Amateur Football

    Sponsor: Riphah International University. Phase: NA. Conditions: Sports Physical Therapy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05934149: Lupus Landmark Study: A Prospective Registry and Biorepository

    Sponsor: Lupus Research Alliance. Phase: . Conditions: Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Neuropsychiatric Systemic Lupus Erythematosus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07327138: Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.

    Sponsor: Bahaa Bou Dargham. Phase: NA. Conditions: Acute Lymphoblastic Leukemia ALL

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05656248: Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms

    Sponsor: St. Jude Children's Research Hospital. Phase: PHASE2. Conditions: Myeloid Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07286955: Life Skills Training for Soldiers Arriving at Their First Duty Location

    Sponsor: Uniformed Services University of the Health Sciences. Phase: NA. Conditions: Risk Reduction Behavior, Suicide Prevention, Risky Behavior, Mental Health, Resilience, Performance at Work

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05905926: Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C

    Sponsor: Ardelyx. Phase: PHASE3. Conditions: Irritable Bowel Syndrome With Constipation (IBS-C)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04784585: Miro-randomized Trial for Optimizing a JITAI to Reduce Dietary Lapses in Obesity Treatment

    Sponsor: The Miriam Hospital. Phase: NA. Conditions: Obesity

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07223008: Bilateral Embolization of the Middle Meningeal Arteries for Refractory Chronic Migraine

    Sponsor: Johns Hopkins University. Phase: NA. Conditions: Migraine, Chronic Migraine Headache, Refractory Migraine

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05371808: Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

    Sponsor: Canadian Cancer Trials Group. Phase: . Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05433025: A Novel Device for Neck Pain in Active-duty Military Personnel With Forward Head Posture.

    Sponsor: Kessler Foundation. Phase: NA. Conditions: Neck Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07519876: Pulmonary Embolism and Right-to-Left Shunts

    Sponsor: Tufts Medical Center. Phase: . Conditions: Pulmonary Embolism (PE), Right-to-Left Shunt, Stroke, Atrial Septal Defects, Patent Foramen Ovale (PFO), Pulmonary Arteriovenous Malformation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07193407: INOPASE - Performance and Safety Study of a Personalised SNM System

    Sponsor: INOPASE Pty Ltd. Phase: NA. Conditions: Overactive Bladder (OAB)

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT07429591: Risk Screening & Primary Prevention of Elder Abuse in People Living With Dementia

    Sponsor: University of Southern California. Phase: NA. Conditions: Caregivers of Alzheimer&#39;s Disease or Memory Problem Patients, Caregiver Wellbeing, Elder Abuse

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05432297: Preventive Physical Activity Intervention in Head and Neck Cancer

    Sponsor: Sahlgrenska University Hospital. Phase: NA. Conditions: Head and Neck Neoplasms, Physical Inactivity

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07442110: This Observational Study Evaluates the Clinical Outcomes of Patients With Diabetes Who Utilize a Specialized Dietary Supplements for Foot Ulcer Healing. The Study Documents the Rate of Complete Wound Closure and the Prevention of Lower Extremity Amputations in a Real-world, At-home Setting.

    Sponsor: Amar h Zireg. Phase: . Conditions: Limb Salvage, Diabetes Complication, Dietary Supplements, Healed Ulcer, Wound Closure, At Home Setting, Diabetes Mellitus, Type 1, Type 2, Wound Healing, Diabetic Foot Ulcer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07254910: Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma

    Sponsor: University of Oklahoma. Phase: NA. Conditions: CRC Screening, CRC (Colorectal Cancer)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07245810: Stryker Facial iD Universal Plate Configurator: A Retrospective Post Market Follow Up

    Sponsor: Stryker Craniomaxillofacial. Phase: . Conditions: Mandibular Fractures, Facial Fracture, Maxilla Fracture, Orthognathic Surgical Procedures

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07462910: Diaphragmatic Evaluation by Fluoroscopy to Identify Phrenic Nerve Dysfunction Related to Electroporation

    Sponsor: French Cardiology Society. Phase: NA. Conditions: Atrial Fibrillation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07523360: A Digital Cognitive Intervention for Intrusive Memories After Trauma

    Sponsor: Zhu Zijian. Phase: NA. Conditions: Post-Traumatic Stress Disorder (PTSD), Intrusive Memories of Traumatic Event(s)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06820320: Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy

    Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: PHASE2. Conditions: Chylous Ascites, Abdominal Neoplasm, Pelvic Neoplasms, Retroperitoneal Lymph Node Metastasis, Retroperitoneal Lymphadenectomy, Extended Lymphadenectomy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04746820: Functional Near-infrared Spectroscopy in Unconscious Patients

    Sponsor: Emanuela Keller. Phase: NA. Conditions: Nervous System Diseases, Healthy Subjects

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06563323: Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)

    Sponsor: Oregon Health and Science University. Phase: PHASE2. Conditions: Pyoderma Gangrenosum, Skin Diseases, Wound Heal, Pyoderma, Skin Ulcer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07525596: Social Work-Supported Physiotherapy and Psychosocial Outcomes in Third Age University and Nursing Home Residents

    Sponsor: Munzur University. Phase: NA. Conditions: Social Work, Psychiatric, Physiotherapy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05003362: ACT for High Frequency Migraine; A Virtual Mindfulness Intervention

    Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Migraine

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07537062: The EFFECT of VİRTUAL REALİTY HEADSETS on ANXİETY, FEAR and PHYSİOLOGICAL PARAMETERS in CHİLDREN With CANCER UNDERGOİNG INTRATHECAL CHEMOTHERAPY

    Sponsor: TC Erciyes University. Phase: NA. Conditions: Pediatric Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06705803: Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)

    Sponsor: University of Chicago. Phase: . Conditions: Prostate Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01742403: Continuous Monitoring of Prostate Position During Radiotherapy

    Sponsor: Royal North Shore Hospital. Phase: NA. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07461727: An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver Metastases

    Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: PHASE1. Conditions: Non-Small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer, Liver Metastases, EGFR Gene Mutation, EGFR L858R

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05026827: Iyengar Yoga for Prolonged Grief Disorder

    Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Prolonged Grief Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03295227: Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Stage III Thymoma AJCC v8, Stage IIIA Thymoma AJCC v8, Stage IIIB Thymoma AJCC v8, Stage IV Thymoma AJCC v8, Stage IVA Thymoma AJCC v8, Stage IVB Thymoma AJCC v8, Unresectable Thymic Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06905561: Topical Diclofenac for Prevention of Radiation-induced Dermatitis

    Sponsor: The Second Affiliated Hospital of Hainan Medical University. Phase: NA. Conditions: Head and Neck Tumor, Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07526961: Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland

    Sponsor: Bristol-Myers Squibb. Phase: . Conditions: Non-Small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07325461: Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes

    Sponsor: Tandem Diabetes Care, Inc.. Phase: NA. Conditions: Diabetes Mellitus, Type 1

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04864886: Metabolic Profiling of Immune Responses in Immune-mediated Diseases

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Primary Immunodeficiency, Psoriasis, Atopic Dermatitis, Immune-mediated Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07447570: Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC

    Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE2. Conditions: Head and Neck Cancer, Radiotherapy, Anti-PD-1/CTLA-4 Antibody

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07326670: Effects of Spinal vs General Anesthesia on Systemic Inflammation in PCNL

    Sponsor: Elazıg Fethi Sekin Sehir Hastanesi. Phase: . Conditions: Anesthesia Techniques, Percutaneous Nephrolithotomy, Systemic Inflammation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06991270: OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma

    Sponsor: Sight Sciences, Inc.. Phase: NA. Conditions: Primary Open Angle Glaucoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06397573: Ablative Stereotactic MR-Guided Adaptive Reirradiation

    Sponsor: Baptist Health South Florida. Phase: NA. Conditions: Abdominal Cancer, Pelvic Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05010473: Cortical Contributions to Frequency Following Responses and Modulation

    Sponsor: Northwestern University. Phase: NA. Conditions: Language

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06609473: Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors

    Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Childhood Cancer, Childhood Cancer Survivors

    full page →ctgov ↗
    ← prev
    page 65 of 162
    next →